No increased mortality in patients with rheumatoid arthritis: Up to 10 years of follow up from disease onset

Annals of the Rheumatic Diseases

Volumn 59, Issue 12, 2000, Pages 954-958

  Kroot, E J A ^a   Van Leeuwen, M A ^b   Van Rijswijk, M H ^b   Prevoo, M L L ^a   Van 't Hof, M A ^a   Van De Putte, L B A ^a   Van Riel, P L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GOLD; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CAUSE OF DEATH; FEMALE; HEALTH STATUS; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; PROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0033637658     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.12.954     Document Type: Article

References (41)

1. Survival, prognosis, and causes of death in rheumatoid arthritis
2. Survival and cause of death in rheumatoid arthritis: A 25-year prospective followup
3. Arthritis and mortality in the epidemiological follow-up to the National Health and Nutrition Examination Survey I
4. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well
5. Mortality in rheumatoid arthritis: Have we made an impact in 4 decades?
6. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
7. Quantitative measures to assess, monitor and predict morbidity and mortality in rheumatoid arthritis
8. Mortality in rheumatoid arthritis
9. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years
10. The natural history of rheumatoid arthritis over 20 years. Clinical symptoms, radiological signs, treatment, mortality and prognostic significance of early features
11. Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis
12. Mortality in rheumatoid arthritis patients with disease onset in the 1980s
13. Functional impairment and disability in early rheumatoid arthritis -development over 5 years
14. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died
15. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study
16. Mortality predictors among 263 patients with rheumatoid arthritis
17. Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis
18. Taking mortality in rheumatoid arthritis seriously - Predictive markers, socioeconomic status and comorbidity
19. Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis
20. Mortality in the rheumatic diseases
21. Long-term outcomes in rheumatoid arthritis
22. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis
23. The mortality of rheumatoid arthritis
24. Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study
25. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
26. Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score
27. Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxochloroquine vs. sulphasalazine
28. Longterm usage and side-effect profile of sulphasalazine in rheumatoid arthritis
29. Comorbidity of chronic diseases in general practice
30. Prevalence of chronic unrelated diseases in patients with rheumatoid arthritis
31. Socio-economic consequences of rheumatoid arthritis in the first years of the disease
32. Rheumatoid arthritis: Evaluation and management: Early and established disease
33. Early treatment of rheumatoid arthritis: Rationale, evidence, and implications
34. Mortality in rheumatoid arthritis
35. Increased mortality in rheumatoid arthritis
36. Mortality from rheumatoid arthritis in France, 1970-1990
37. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study
38. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis
39. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden
40. Mortality in rheumatoid arthritis: Do age and gender make a difference?